Work

Supplemental Figure from Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells

Year: 2023

Type: supplementary-materials

Abstract: SKBR3 breast cancer cells shed HER2 after treatment with chemotherapy or irradiation.

DOI: 10.1158/0008-5472.22415321.v1

Authors: Victor A. Gall, Anne V. Philips, Na Qiao, Karen Clise-Dwyer, Alexander A. Perakis, Mao Zhang, Guy T. Clifton, Pariya Sukhumalchandra, Qing Ma, Sangeetha M. Reddy, Dihua Yu, Jeffrey J. Molldrem, George E. Peoples, Gheath Alatrash, Elizabeth A. Mittendorf

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362422007

Cites:

Cited by:

Related to: 10